Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-31 @ 4:39 AM
Study NCT ID:
NCT06757335
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-01-03
First Post:
2024-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
Sponsor:
Hinova Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-07
First Submit QC Date:
None
Study First Post Date:
2025-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-01
Last Update Post Date:
2025-01-03
Last Update Post Date Type:
ACTUAL